Experimental Zygomycosis
Posaconazole is most effective against the zygomycete Rhizopus microsporus
Published in TB and Outbreaks Week, January 6th, 2004
According to a study from France, "Three isolates of zygomycetes were used to produce a disseminated infection in nonimmunocompromised mice. Against all zygomycete strains, amphotericin B significantly prolonged survival.
"Itraconazole was inactive against Rhizopus microsporus and R. oryzae but was partially active against Absidia corymbifera. Posaconazole had no beneficial effects against R. oryzae but showed partial activity against A. corymbifera," wrote E. Dannaoui...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Food-borne Disease
Salmonella enterica serovar Enteritidis YafD protects against egg albumen - Antibiotc Prescribing
California partnership takes lead on simplifying guidelines - Antibiotic Resistance
V. cholerae's resistance genes can leave host, integrate into new one - Antifungal Proteins
Penicillium chrysogenum can inhibit some aspergilli with PAF protein - Antimicrobial Proteins
Gastric epithelial cells produce beta-defensins after H. pylori infection - Antimicrobial Proteins
Lactoferrin-derived peptides have antimicrobial activity beyond iron depletion - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
